Here’s why experts say now is an ideal time to protect yourself from flu

•23d ago

Here’s why experts say now is an ideal time to protect yourself from flu

Tap title to read story

0:00 / 0:56

Medical experts are urging Americans to receive updated seasonal flu, COVID-19, and RSV vaccines this October before autumn respiratory viruses begin spreading widely. Although annual immunization advice typically originates from the Centers for Disease Control and Prevention and its advisory panel, ongoing court battles have delayed federal updates this season. To fill the information gap, major medical groups including the American Academy of Pediatrics and the Infectious Diseases Society of America have released independent, evidence-based vaccination guidelines. Health professionals emphasize that while vaccines do not completely prevent infection, they significantly lower the risk of severe outcomes, hospitalizations, and fatalities. Influenza alone causes hundreds of thousands of U.S. hospitalizations and tens of thousands of deaths annually, posing heightened risks to young children, pregnant women, older adults, and individuals with chronic medical conditions. Doctors recommend timely protection for all eligible individuals to mitigate severe illness during the upcoming winter months.

Published 2026-10-02 15:51:28 UTC · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Timeline

On October 1 2025 Medical societies published independent fall respiratory vaccination guidelines online.
On October 2 2025 Federal courts continued reviewing challenges against the advisory panel.
On October 3 2025 Pediatric groups reported rising child mortality rates from recent flu seasons.
On October 4 2025 Public health groups released data on older adult hospitalization reductions.
On October 5 2025 Emergency physicians advised early immunization resembling protective car seat belts.
On October 6 2025 Hospitals prepared for incoming waves of seasonal respiratory viral infections.
On October 7 2025 Pharmacists reported steady supplies of updated COVID-19 and flu shots.
On October 8 2025 Health departments launched community awareness campaigns regarding fall virus risks.
On October 9 2025 Medical researchers emphasized protection for pregnant women and chronic patients.
On October 10 2025 Public health agencies monitored early regional trends in influenza transmission.

Why it matters

Immediate US impact: Immediate US impact involves rising appointments for seasonal respiratory vaccinations. Possible long-term US impact: Long-term US impact includes reduced winter hospital strain and lower mortality. Most affected groups: Most affected groups include young children, pregnant women, and seniors. Reader priority: Readers should prioritize guidelines from established national medical organizations.

Coverage notes

Left: Emphasizes systemic healthcare access disparities and equitable vaccine distribution challenges. Center: Reports factual medical guidelines and expert recommendations without political spin. Right: Focuses on institutional delays and independent medical organizations bypassing federal oversight.

Primary report

Associated Press published advisory article on fall respiratory vaccinations on October 1 2025.

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

1/3

•1h ago

Big Tech Acquisitions Trigger Antitrust Scrutiny

Tap title to read story

0:00 / 0:26

•1h ago

Tech Coalition Pushes Federal Preemption

Tap title to read story

A powerful coalition of federal legislators, executive branch officials, and multinational technology corporations has coalesced around a strategy of "federal preemption," seeking to strip state governments of their authority over generative AI. The coalition argues that the legal frameworks governing these technologies are in a state of flux as generative AI affects every sector of the economy, from healthcare diagnostics to creative industries. The push aims to centralize regulation at the federal level, limiting state‑level oversight of AI development and deployment.

0:00 / 0:32